Universal flu vaccine candidate demonstrates preclinical success 31-Oct-2018 By Maggie Lynch InvVax’s universal flu vaccine candidate has demonstrated preclinical success as the company prepares for a Phase I clinical trial, supported by a Series A fundraising round.